Artificial Intelligence in Diabetes Management Market Research Report by Type (Diagnostics, Treatment Planning, Data Management, Patient Self-Management), by Deployment (Cloud-Based, On-Premises, Hybrid), by Application (Type 1 Diabetes, Type 2 Diabetes,
Description
The Global Artificial Intelligence in Diabetes Management Market is set for substantial growth, rising from USD 1,568.64 million in 2024 to USD 14,239.56 million by 2035. With a CAGR of 22.76% between 2025 and 2035, the market is driven by growing demand for intelligent and data-driven diabetes care solutions.
Rising Demand for Real-Time and Preventive Care Solutions
The use of artificial intelligence in mobile health apps, cloud platforms, and telemedicine is really changing the game for diabetes care. This digital system is not only getting patients more involved in their care, but it's also making disease management more efficient and scalable.
Key Segment Breakdown
By Type
• Diagnostics: AI improves speed and accuracy of diagnosis
• Treatment Planning: Data-driven insights optimize individualized treatment plans
• Data Management: Secure storage and analysis of patient data
• Patient Self-Management: Apps and devices aid daily glucose control
By Deployment
• Cloud-Based: Enables flexible, scalable, and remote data management
• On-Premises: Provides enhanced privacy and infrastructure control
• Hybrid: Integrates cloud scalability with on-site security
By Application
• Type 1 Diabetes: Real-time tracking with precise insulin adjustments
• Type 2 Diabetes: AI aids long-term disease and lifestyle management
• Gestational Diabetes: Monitoring ensures safe pregnancy outcomes
By End-User
• Hospitals and Clinics: AI assists clinicians in accurate decision-making
• Ambulatory Surgical Centers: Improves efficiency in short-term care settings
• Diabetes Treatment Centers: Specialized AI tools for comprehensive management
• Patients: Empowers users with personalized self-management solutions
Global Regional Insights
North America is leading the way with its high adoption and investment in AI, followed closely by Europe's strong healthcare system, which is driven by regulations. The Asia Pacific region is growing rapidly, and while South America and the Middle East and Africa are still catching up, it's the large patient groups in other areas that are really driving progress.
Transformational Biopharma AI Partnership
In May 2024, Sanofi collaborated with Formation Bio and OpenAI in a first-of-its-kind alliance to integrate AI across the drug development value chain. This move supports Sanofi’s vision of becoming a fully AI-powered biopharmaceutical leader through advanced data utilization and scalable AI solutions.
Next-Generation Clinical Optimization
The focus is on using data-driven insights and customized AI models to transform innovation in the biopharma industry. This is a big deal, and it could lead to some major breakthroughs in the way we develop new treatments. These capabilities allow clinicians to predict risks, personalize treatments, and enhance overall efficiency in diabetes care delivery.
Key Report Attributes
• Market Size 2024: USD 1568.64 Million
• Market Size 2035: USD 14239.56 Million
• CAGR (2025-2035): 22.76%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Type: Diagnostics - 23.03%, Treatment Planning - 22.27%.
• By Deployment: Cloud-Based - 23.68%, On-Premises - 22.21%.
• By Application: Type 1 Diabetes - 25.39%, Type 2 Diabetes - 22.43%.
• By end-User: Hospitals and Clinics - 22.05%, Ambulatory Surgical Centers - 22.34%.
Rising Demand for Real-Time and Preventive Care Solutions
The use of artificial intelligence in mobile health apps, cloud platforms, and telemedicine is really changing the game for diabetes care. This digital system is not only getting patients more involved in their care, but it's also making disease management more efficient and scalable.
Key Segment Breakdown
By Type
• Diagnostics: AI improves speed and accuracy of diagnosis
• Treatment Planning: Data-driven insights optimize individualized treatment plans
• Data Management: Secure storage and analysis of patient data
• Patient Self-Management: Apps and devices aid daily glucose control
By Deployment
• Cloud-Based: Enables flexible, scalable, and remote data management
• On-Premises: Provides enhanced privacy and infrastructure control
• Hybrid: Integrates cloud scalability with on-site security
By Application
• Type 1 Diabetes: Real-time tracking with precise insulin adjustments
• Type 2 Diabetes: AI aids long-term disease and lifestyle management
• Gestational Diabetes: Monitoring ensures safe pregnancy outcomes
By End-User
• Hospitals and Clinics: AI assists clinicians in accurate decision-making
• Ambulatory Surgical Centers: Improves efficiency in short-term care settings
• Diabetes Treatment Centers: Specialized AI tools for comprehensive management
• Patients: Empowers users with personalized self-management solutions
Global Regional Insights
North America is leading the way with its high adoption and investment in AI, followed closely by Europe's strong healthcare system, which is driven by regulations. The Asia Pacific region is growing rapidly, and while South America and the Middle East and Africa are still catching up, it's the large patient groups in other areas that are really driving progress.
Transformational Biopharma AI Partnership
In May 2024, Sanofi collaborated with Formation Bio and OpenAI in a first-of-its-kind alliance to integrate AI across the drug development value chain. This move supports Sanofi’s vision of becoming a fully AI-powered biopharmaceutical leader through advanced data utilization and scalable AI solutions.
Next-Generation Clinical Optimization
The focus is on using data-driven insights and customized AI models to transform innovation in the biopharma industry. This is a big deal, and it could lead to some major breakthroughs in the way we develop new treatments. These capabilities allow clinicians to predict risks, personalize treatments, and enhance overall efficiency in diabetes care delivery.
Key Report Attributes
• Market Size 2024: USD 1568.64 Million
• Market Size 2035: USD 14239.56 Million
• CAGR (2025-2035): 22.76%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Type: Diagnostics - 23.03%, Treatment Planning - 22.27%.
• By Deployment: Cloud-Based - 23.68%, On-Premises - 22.21%.
• By Application: Type 1 Diabetes - 25.39%, Type 2 Diabetes - 22.43%.
• By end-User: Hospitals and Clinics - 22.05%, Ambulatory Surgical Centers - 22.34%.
Table of Contents
183 Pages
- 1 Executive Summary
- 2 Market Introduction
- 2.1 Definition
- 2.2 Scope Of The Study
- 2.3 Research Objective
- 2.4 Market Structure
- 3 Research Methodology
- 3.1 Overview
- 3.2 Data Flow
- 3.2.1 Data Mining Process
- 3.3 Purchased Database:
- 3.4 Secondary Sources:
- 3.4.1 Secondary Research Data Flow:
- 3.5 Primary Research:
- 3.5.1 Primary Research Data Flow:
- 3.5.2 Primary Research: Number Of Interviews Conducted
- 3.5.3 Primary Research: Regional Coverage
- 3.6 Approaches For Market Size Estimation:
- 3.6.1 Revenue Analysis Approach
- 3.7 Data Forecasting
- 3.7.1 Data Forecasting Type
- 3.8 Data Modeling
- 3.8.1 Microeconomic Factor Analysis:
- 3.8.2 Data Modeling:
- 3.9 Teams And Analyst Contribution
- 4 Market Dynamics
- 4.1 Introduction
- 4.2 Drivers
- 4.2.1 Rising Global Diabetes Prevalence
- 4.2.2 Advancements In Connected Devices And Digital Health Infrastructure
- 4.2.3 Shift Toward Personalized And Predictive Healthcare
- 4.2.4 Increased Adoption Of Cloud And Saas Healthcare Platforms
- 4.3 Restraints
- 4.3.1 High Implementation And Integration Costs
- 4.3.2 Data Privacy And Cybersecurity Concerns
- 4.3.3 Limited Interoperability Across Devices And Ehr Systems
- 4.4 Opportunities
- 4.4.1 Expansion Of Remote Patient Monitoring (Rpm) And Telehealth
- 4.4.2 Emergence Of Generative Ai And Predictive Analytics
- 4.4.3 Partnerships Between Tech Giants And Healthcare Providers
- 5 Market Factor Analysis
- 5.1 Value Chain Analysis
- 5.1.1 Data Generation & Acquisition
- 5.1.2 Data Processing & Storage
- 5.1.3 Ai Model Development
- 5.1.4 Integration With Devices & Platforms
- 5.1.5 Clinical Validation & Regulatory Approval
- 5.1.6 Deployment & Commercialization
- 5.1.7 Patient Engagement & Feedback
- 5.1.8 Continuous Learning & Model Optimization
- 5.2 Porter's Five Forces Model
- 5.2.1 Threat Of New Entrants
- 5.2.2 Bargaining Power Of Suppliers
- 5.2.3 Threat Of Substitutes
- 5.2.4 Bargaining Power Of Buyers
- 5.2.5 Intensity Of Rivalry
- 5.3 Covid-19 Impact Analysis
- 6 Global Artificial Intelligence In Diabetes Management Market, By Type
- 6.1 Overview
- 6.1.1 Diagnostics
- 6.1.2 Treatment Planning
- 6.1.3 Data Management
- 6.1.4 Patient Self Management
- 7 Global Artificial Intelligence In Diabetes Management Market, By Deployment
- 7.1 Overview
- 7.1.1 Cloud-based
- 7.1.2 On-premises
- 7.1.3 Hybrid
- 8 Global Artificial Intelligence In Diabetes Management Market, By Application
- 8.1 Overview
- 8.1.1 Type 1 Diabetes
- 8.1.2 Type 2 Diabetes
- 8.1.3 Gestational Diabetes
- 9 Global Artificial Intelligence In Diabetes Management Market, By End User
- 9.1 Overview
- 9.1.1 Hospitals And Clinics
- 9.1.2 Ambulatory Surgical Centers
- 9.1.3 Diabetes Treatment Centers
- 9.1.4 Patients
- 10 Global Artificial Intelligence In Diabetes Management Market, By Region
- 10.1 Overview
- 10.2 North America
- 10.2.1 Us
- 10.2.2 Canada
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 France
- 10.3.3 Uk
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Russia
- 10.3.7 Rest Of Europe
- 10.4 Asia-pacific
- 10.4.1 China
- 10.4.2 India
- 10.4.3 Japan
- 10.4.4 South Korea
- 10.4.5 Malaysia
- 10.4.6 Thailand
- 10.4.7 Indonesia
- 10.4.8 Rest Of Asia-pacific
- 10.5 South America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest Of South America
- 10.6 Middle East & Africa
- 10.6.1 Gcc Countries
- 10.6.2 South Africa
- 10.6.3 Rest Of Mea
- 11 Competitive Landscape
- 11.1 Introduction
- 11.2 Market Share Analysis, 2024
- 11.3 Competitor Dashboard
- 11.4 Public Players Stock Summary
- 11.5 Comparative Analysis: Key Players Financial
- 11.1 Key Developments & Growth Strategies
- 11.1.1 Product Launch
- 11.1.2 Partnership
- 11.1.3 Acquisition/ Expansion
- 11.1.4 Ai-enabled
- 12 Company Profiles
- 12.1 Eli Lilly And Company
- 12.1.1 Company Overview
- 12.1.2 Financial Overview
- 12.1.3 Products/ Service Offered
- 12.1.4 Key Developments
- 12.1.5 Swot Analysis
- 12.1.6 Key Strategies
- 12.2 Astrazeneca
- 12.2.1 Company Overview
- 12.2.2 Financial Overview
- 12.2.3 Products Offered
- 12.2.4 Key Developments
- 12.2.5 Swot Analysis
- 12.2.6 Key Strategies
- 12.3 Sanofi
- 12.3.1 Company Overview
- 12.3.2 Financial Overview
- 12.3.3 Products Offered
- 12.3.4 Key Developments
- 12.3.5 Key Strategies
- 12.4 Novo Nordisk A/S
- 12.4.1 Company Overview
- 12.4.2 Financial Overview
- 12.4.3 Products Offered
- 12.4.4 Key Developments
- 12.4.5 Swot Analysis
- 12.4.6 Key Strategies
- 12.5 Tandem Diabetes Care, Inc.
- 12.5.1 Company Overview
- 12.5.2 Financial Overview
- 12.5.3 Products Offered
- 12.5.4 Key Developments
- 12.5.5 Swot Analysis
- 12.5.6 Key Strategies
- 12.6 F. Hoffmann-la Roche Ltd.
- 12.6.1 Company Overview
- 12.6.2 Financial Overview
- 12.6.3 Products/Services Offered
- 12.6.4 Key Developments
- 12.6.5 Swot Analysis
- 12.6.6 Key Strategies
- 12.7 Abbott
- 12.7.1 Company Overview
- 12.7.2 Financial Overview
- 12.7.3 Products/Services Offered
- 12.7.4 Key Developments
- 12.7.5 Key Strategies
- 12.8 Medtronic
- 12.8.1 Company Overview
- 12.8.2 Financial Overview
- 12.8.3 Products/Services Offered
- 12.8.4 Key Developments
- 12.8.5 Swot Analysis
- 12.8.6 Key Strategies
- 12.9 Dexcom Inc.
- 12.9.1 Company Overview
- 12.9.2 Financial Overview
- 12.9.3 Products/Services Offered
- 12.9.4 Key Developments
- 12.9.5 Key Strategies
- 12.10 Insulet Corporation
- 12.10.1 Company Overview
- 12.10.2 Financial Overview
- 12.10.3 Products/Services Offered
- 12.10.4 Key Developments
- 12.10.5 Swot Analysis
- 12.10.6 Key Strategy
- 13 Data Citations
- List Of Tables
- Table 1 Qfd Modeling For Market Share Assessment
- Table 2 Global Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 3 Global Artificial Intelligence In Diabetes Management Market, For Diagnostics, By Region, 2019–2035 (Usd Million)
- Table 4 Global Artificial Intelligence In Diabetes Management Market, For Treatment Planning, By Region, 2019–2035 (Usd Million)
- Table 5 Global Artificial Intelligence In Diabetes Management Market, For Data Management, By Region, 2019–2035 (Usd Million)
- Table 6 Global Artificial Intelligence In Diabetes Management Market, For Patient Self Management, By Region, 2019
- 2035 (Usd Million)
- Table 7 Global Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 8 Global Artificial Intelligence In Diabetes Management Market, For Cloud-based, By Region, 2019–2035 (Usd Million)
- Table 9 Global Artificial Intelligence In Diabetes Management Market, For On-premises, By Region, 2019–2035 (Usd Million)
- Table 10 Global Artificial Intelligence In Diabetes Management Market, For Hybrid, By Region, 2019–2035 (Usd Million)
- Table 11 Global Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 12 Global Artificial Intelligence In Diabetes Management Market, For Type 1 Diabetes, By Region, 2019–2035 (Usd Million)
- Table 13 Global Artificial Intelligence In Diabetes Management Market, For Type 2 Diabetes, By Region, 2019–2035 (Usd Million)
- Table 14 Global Artificial Intelligence In Diabetes Management Market, For Gestational Diabetes, By Region, 2019–2035 (Usd Million)
- Table 15 Global Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 16 Global Artificial Intelligence In Diabetes Management Market, For Hospitals And Clinics, By Region, 2019–2035 (Usd Million)
- Table 17 Global Artificial Intelligence In Diabetes Management Market, For Ambulatory Surgical Centers, By Region, 2019–2035 (Usd Million)
- Table 18 Global Artificial Intelligence In Diabetes Management Market, For Diabetes Treatment Centers, By Region, 2019-2035 (Usd Million)
- Table 19 Global Artificial Intelligence In Diabetes Management Market, For Patients, By Region, 2019–2035 (Usd Million)
- Table 20 Global Artificial Intelligence In Diabetes Management Market, By Region, 2019-2035 (Usd Million)
- Table 21 North America: Artificial Intelligence In Diabetes Management Market, By Country, 2019-2035 (Usd Million)
- Table 22 North America: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 23 North America: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 24 North America: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 25 North America: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 26 Us: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 27 Us: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 28 Us: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 29 Us: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 30 Canada: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 31 Canada: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 32 Canada: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 33 Canada: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 34 Europe: Artificial Intelligence In Diabetes Market, By Country, 2019-2035 (Usd Million)
- Table 35 Europe: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 36 Europe: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 37 Europe: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 38 Europe: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 39 Germany: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 40 Germany: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 41 Germany: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 42 Germany: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 43 France: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 44 France: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 45 France: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 46 France: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 47 Uk: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 48 Uk: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 49 Uk: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 50 Uk: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 51 Spain: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 52 Spain: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 53 Spain: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 54 Spain: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 55 Italy: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 56 Italy: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 57 Italy: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 58 Italy: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 59 Russia: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 60 Russia: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 61 Russia: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 62 Russia: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 63 Rest Of Europe: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 64 Rest Of Europe: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 65 Rest Of Europe: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 66 Rest Of Europe: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 67 Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Country, 2019–2035 (Usd Million)
- Table 68 Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 69 Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 70 Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 71 Asia-pacific: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 72 China: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 73 China: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 74 China: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 75 China: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 76 India: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 77 India: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 78 India: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 79 India: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 80 Japan: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 81 Japan: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 82 Japan: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 83 Japan: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 84 South Korea: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 85 South Korea: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 86 South Korea: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 87 South Korea: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 88 Malaysia: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 89 Malaysia: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 90 Malaysia: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 91 Malaysia: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 92 Thailand: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 93 Thailand: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 94 Thailand: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 95 Thailand: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 96 Indonesia: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 97 Indonesia: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 98 Indonesia: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 99 Indonesia: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 100 Rest Of Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Type, 2019–2035 (Usd Million)
- Table 101 Rest Of Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Deployment, 2019–2035 (Usd Million)
- Table 102 Rest Of Asia-pacific: Artificial Intelligence In Diabetes Management Market, By Application, 2019–2035 (Usd Million)
- Table 103 Rest Of Asia-pacific: Artificial Intelligence In Diabetes Management Market, By End User, 2019–2035 (Usd Million)
- Table 104 South America Artificial Intelligence In Diabetes Management Market, By Country, 2019-2035 (Usd Million)
- Table 105 South America Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 106 South America Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 107 South America Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 108 South America Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 109 Brazil Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 110 Brazil Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 111 Brazil Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 112 Brazil Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 113 Mexico Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 114 Mexico Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 115 Mexico Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 116 Mexico Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 117 Argentina Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 118 Argentina Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 119 Argentina Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 120 Argentina Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 121 Argentina Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 122 Argentina Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 123 Argentina Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 124 Argentina Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 125 Middle East & Africa Artificial Intelligence In Diabetes Management Market, By Country, 2019-2035 (Usd Million)128
- Table 126 Middle East & Africa Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 127 Middle East & Africa Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 128 Middle East & Africa Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 129 Middle East & Africa Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 130 Gcc Countries Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 131 Gcc Countries Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 132 Gcc Countries Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)132
- Table 133 Gcc Countries Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 134 South Africa Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 135 South Africa Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 136 South Africa Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 137 South Africa Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 138 Rest Of Mea Artificial Intelligence In Diabetes Market, By Type, 2019-2035 (Usd Million)
- Table 139 Rest Of Mea Artificial Intelligence In Diabetes Management Market, By Deployment, 2019-2035 (Usd Million)
- Table 140 Rest Of Mea Artificial Intelligence In Diabetes Management Market, By Application, 2019-2035 (Usd Million)
- Table 141 Rest Of Mea Artificial Intelligence In Diabetes Management Market, By End User, 2019-2035 (Usd Million)
- Table 142 Product Launch
- Table 143 Partnership
- Table 144 Acquisition/ Expansion
- Table 145 Ai-enabled
- Table 146 Eli Lilly And Company: Products Offered
- Table 147 Astrazeneca: Products Offered
- Table 148 Sanofi: Products Offered
- Table 149 Sanofi: Key Developments
- Table 150 Novo Nordisk A/S: Products Offered
- Table 151 Tandem Diabetes Care, Inc.: Products Offered
- Table 152 Tandem Diabetes Care, Inc.: Key Developments
- Table 153 F. Hoffmann-la Roche Ltd.: Products Offered
- Table 154 F. Hoffmann-la Roche Ltd.: Products Offered
- Table 155 Abbott.: Products/Services Offered
- Table 156 Medtronic: Products/Services Offered
- Table 157 Medtronic: Key Developments
- Table 158 Dexcom, Inc: Products/Services Offered
- Table 159 Insulet Corporation.: Products/Services Offered
- Table 160 F. Hoffmann-la Roche Ltd.: Products Offered
- List Of Figures
- Figure 1 Global Artificial Intelligence (Ai) In Diabetes Management Market: Structure
- Figure 1 Global Artificial Intelligence In Diabetes Management Market: Market Growth Affecting Factor Analysis (2019-2035)
- Figure 2 Share Of People With Diabetes, 2024
- Figure 3 Global Artificial Intelligence In Diabetes Management Market Driver: Impact Analysis
- Figure 4 Global Artificial Intelligence In Diabetes Management Market Restraint: Impact Analysis
- Figure 5 Porter's Five Forces Analysis: Global Artificial Intelligence (Ai) In Diabetes Management Market
- Figure 6 Global Artificial Intelligence In Diabetes Management Market, Type Segment Attractiveness, 2024 & 2035 (Usd Million)
- Figure 7 Global Artificial Intelligence In Diabetes Management Market, By Type, 2024 & 2035 (Usd Million)
- Figure 8 Global Artificial Intelligence In Diabetes Management Market Share (%), By Type, 2024
- Figure 9 Global Artificial Intelligence In Diabetes Management Market, Deployment Segment Attractiveness, 2024 & 2035
- (Usd Million)
- Figure 10 Global Artificial Intelligence In Diabetes Management Market, By Deployment, 2024 & 2035 (Usd Million)
- Figure 11 Global Artificial Intelligence In Diabetes Management Market Share (%), By Deployment, 2024
- Figure 12 Global Artificial Intelligence In Diabetes Management Market, Application Segment Attractiveness, 2024 & 2035 (Usd Million)
- Figure 13 Global Artificial Intelligence In Diabetes Management Market, By Application, 2024 & 2035 (Usd Million)
- Figure 14 Global Artificial Intelligence In Diabetes Management Market Share (%), By Application, 2024
- Figure 15 Global Artificial Intelligence In Diabetes Management Market, End User Segment Attractiveness, 2024 & 2035 (Usd Million)
- Figure 16 Global Artificial Intelligence In Diabetes Management Market, By End User, 2024 & 2035 (Usd Million)
- Figure 17 Global Artificial Intelligence In Diabetes Management Market Share (%), By End User, 2024
- Figure 18 Global Artificial Intelligence In Diabetes Management Market, By Region, 2024 & 2035 (Usd Million)
- Figure 19 Global Artificial Intelligence In Diabetes Management Market Share (%), By Region, 2024
- Figure 20 North America Market Analysis: Artificial Intelligence In Diabetes Management Market, 2019-2035 (Usd Million)
- Figure 21 North America: Artificial Intelligence In Diabetes Management Market, By Country, 2024 & 2035 (Usd Million)
- Figure 22 North America: Artificial Intelligence In Diabetes Management Market Share (%), By Country, 2024
- Figure 23 Europe Market Analysis: Artificial Intelligence In Diabetes Management Market, 2019-2035 (Usd Million)
- Figure 24 Europe: Artificial Intelligence In Diabetes Management Market, By Country, 2024 & 2035 (Usd Million)
- Figure 25 Europe: Artificial Intelligence In Diabetes Management Market Share (%), By Country, 2024
- Figure 1 Asia-pacific Market Analysis: Artificial Intelligence In Diabetes Management Market, 2019-2035 (Usd Million)
- Figure 2 Asia-pacific: Artificial Intelligence In Diabetes Management Market Share, By Country, 2024 & 2035 (Usd Million)
- Figure 3 Asia-pacific: Artificial Intelligence In Diabetes Management Market Share, By Country, 2024 (%)
- Figure 4 South America Artificial Intelligence In Diabetes Management Market: Swot Analysis
- Figure 5 South America Artificial Intelligence In Diabetes Management Market (, By Country, 2024 & 2035 (Usd Million)
- Figure 6 South America Artificial Intelligence In Diabetes Management Market Share (%), By Country, 2024
- Figure 7 Middle East And Africa Artificial Intelligence In Diabetes Management Market: Swot Analysis
- Figure 8 Middle East And Africa Artificial Intelligence In Diabetes Management Market (, By Country, 2024 & 2035 (Usd Million)
- Figure 9 Middle East & Africa Artificial Intelligence In Diabetes Management Market Share (%), By Country, 2024
- Figure 10 Global Artificial Intelligence In Diabetes Management Market Players: Competitive Analysis, 2024
- Figure 11 Competitor Dashboard: Global Artificial Intelligence In Diabetes Management Market
- Figure 12 Eli Lilly And Company: Financial Overview Snapshot
- Figure 13 Eli Lilly And Company: Swot Analysis
- Figure 14 Astrazeneca: Financial Overview Snapshot
- Figure 15 Astrazeneca: Swot Analysis
- Figure 16 Sanofi: Financial Overview Snapshot
- Figure 17 Novo Nordisk A/S: Financial Overview Snapshot
- Figure 18 Novo Nordisk A/S: Swot Analysis
- Figure 19 Tandem Diabetes Care, Inc.: Financial Overview Snapshot
- Figure 20 Tandem Diabetes Care, Inc.: Swot Analysis
- Figure 21 F. Hoffmann-la Roche Ltd.: Financial Overview Snapshot
- Figure 22 F. Hoffmann-la Roche Ltd.: Swot Analysis
- Figure 23 Abbott: Financial Overview Snapshot
- Figure 24 Medtronic: Financial Overview Snapshot
- Figure 25 Medtronic: Swot Analysis
- Figure 26 Dexcom, Inc.: Financial Overview Snapshot
- Figure 27 Insulet Corporation.: Financial Overview Snapshot
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
